TTK Healthcare Limited has informed the Exchange regarding 'BRSR FY 2024-25'.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TTK Healthcare Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25 to BSE and NSE, as required under SEBI LODR Regulation 34(2)(f). The company is a diversified healthcare player with reported turnover of Rs. 80,149.34 lakhs and net worth of Rs. 1,04,257.49 lakhs, manufacturing and marketing male contraceptives, food products, animal welfare products, ayurvedic preparations, medical devices, home care, and cosmetics across 8 plants and 37 offices. The report discloses 1,287 employees and 2,368 workers, 6,393 dealers/distributors, exports to 54 countries (10.66% of turnover), ISO certifications, and 100% health & safety assessments of plants. It also flags one worker fatality and 22 recordable work-related injuries during the year, and a fine of Rs. 2.70 lakhs each (plus GST) paid to BSE and NSE for delayed compliance with the woman director requirement under Regulation 17(1), against which an appeal has been filed.
This is a routine annual ESG/sustainability compliance filing and is unlikely to move the stock price on its own. The disclosed worker fatality and regulatory fine for delayed woman director appointment are minor negatives, while the diverse product portfolio, broad distribution network, and sustainability initiatives (70% sustainable sourcing, ISO certifications) reinforce the steady-state nature of the business.